Eckert & Ziegler SE 1EUZ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- €41.94
- Day Range
- €41.68–41.68
- 52-Week Range
- €36.82–46.12
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €929.71 Mil
- Volume/Avg
- 50 / 27
Key Statistics
- Price/Earnings (Normalized)
- 21.29
- Price/Sales
- 3.16
- Dividend Yield (Trailing)
- 0.12%
- Dividend Yield (Forward)
- 0.12%
- Total Yield
- 0.12%
Company Profile
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,085
- Website
- https://www.ezag.com
Comparables
Valuation
|
Metric
|
1EUZ
|
603658
|
688606
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.29 | 18.92 | 26.11 |
Price/Book Value | 3.50 | 2.95 | 1.24 |
Price/Sales | 3.16 | 5.27 | 6.19 |
Price/Cash Flow | 15.92 | 13.29 | 18.86 |
Price/Earnings
1EUZ
603658
688606
Financial Strength
|
Metric
|
1EUZ
|
603658
|
688606
|
|---|---|---|---|
Quick Ratio | 1.61 | 0.99 | 7.73 |
Current Ratio | 2.91 | 2.71 | 8.43 |
Interest Coverage | 13.67 | 57.12 | 235.62 |
Quick Ratio
1EUZ
603658
688606
Profitability
|
Metric
|
1EUZ
|
603658
|
688606
|
|---|---|---|---|
Return on Assets (Normalized) | 9.20% | 11.37% | 4.14% |
Return on Equity (Normalized) | 18.11% | 15.28% | 4.49% |
Return on Invested Capital (Normalized) | 15.11% | 14.14% | 3.52% |
Return on Assets
1EUZ
603658
688606
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Pfbmfmcq | Jqvzxbc | $196.1 Bil | |||
| Stryker Corp
SYK
| Lgldwcrs | Zhlm | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Rrjbwrm | Lwpdn | $122.3 Bil | |||
| Medtronic PLC
MDT
| Xkxbbgdjs | Xsggq | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Dhqspzqyjx | Nnrcxt | $39.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Pxqmf | Xdvlt | $29.3 Bil | |||
| DexCom Inc
DXCM
| Qhfmqwsxy | Wph | $27.1 Bil | |||
| Steris PLC
STE
| Ylxcnnvg | Bxjqvcn | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Fxzdrrkdhv | Ryr | $21.9 Bil | |||
| Insulet Corp
PODD
| Tfpjlcwh | Cjvdgp | $16.5 Bil |
United States